SIP
MEDP icon

Stoneridge Investment Partners’s Medpace MEDP Stock Holding History

Stoneridge Investment Partners’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-26,844
Closed -$778K – 275
2017
Q2 		$778K Buy
+26,844
New +$753K 0.12% 125

Other funds holding MEDP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCA
Bernzott Capital Advisors Camarillo, California $250M AUM 26.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stoneridge Investment Partners's MEDP Position: Q3 2017 in Review

Stoneridge Investment Partners sold out of Medpace (MEDP) in Q3 2017, closing a stake of 26,844 shares — an estimated $778K sold.

Stoneridge Investment Partners first reported a position in MEDP in Q2 2017 and held it in 1 quarter. The position peaked at $778K in Q2 2017. 86 funds tracked by Wall St. Rank hold MEDP as of Q3 2017.

  • Stoneridge Investment Partners reported no remaining Medpace position as of Q3 2017 after selling out during the quarter.
  • Stoneridge Investment Partners sold 26,844 Medpace shares in Q3 2017, an estimated $778K.
  • Stoneridge Investment Partners first reported a position in Medpace in Q2 2017 and held it in 1 quarter.
  • Stoneridge Investment Partners's Medpace position peaked at $778K in Q2 2017.
  • 86 funds tracked by Wall St. Rank held Medpace as of Q3 2017.

Based on Stoneridge Investment Partners's 13F filing for Q3 2017, filed 2 Nov 2017.